Pfizer agrees to let other companies make its Covid pill to allow broader global access

Pfizer agrees to let other companies make its Covid pill to allow broader global access

Drugmaker Pfizer Inc. has signed a deal with a U.N.-backed group to allow other manufacturers to make its experimental Covid-19 pill, a move that could make the treatment available to more than half of the world’s population.